GUTS (Fractyl Health) Days Inventory : 0.00 (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Fractyl Health Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Fractyl Health's Average Total Inventories for the three months ended in Dec. 2024 was $0.07 Mil. Fractyl Health's Cost of Goods Sold for the three months ended in Dec. 2024 was $0.00 Mil.

The historical rank and industry rank for Fractyl Health's Days Inventory or its related term are showing as below:

GUTS' s Days Inventory Range Over the Past 10 Years
Min: 346.04 Med: 439.47 Max: 532.9
Current: 519.76

During the past 6 years, Fractyl Health's highest Days Inventory was 532.90. The lowest was 346.04. And the median was 439.47.

GUTS's Days Inventory is ranked worse than
82.89% of 643 companies
in the Biotechnology industry
Industry Median: 177.91 vs GUTS: 519.76

Fractyl Health's Days Inventory declined from Dec. 2023 (3,399.06) to Dec. 2024 (0.00).

Inventory Turnover measures how fast the company turns over its inventory within a year. Fractyl Health's Inventory Turnover for the three months ended in Dec. 2024 was 0.00.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Fractyl Health's Inventory-to-Revenue for the three months ended in Dec. 2024 was 24.33.

Fractyl Health Days Inventory Historical Data

The historical data trend for Fractyl Health's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fractyl Health Days Inventory Chart

Fractyl Health Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Inventory

Get a 7-Day Free Trial

346.04

532.90

Fractyl Health Quarterly Data
	Dec19	Sep20	Dec20	Jun21	Sep21	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Days Inventory	Get a 7-Day Free Trial											3,399.06	350.59	260.44	892.95	-

Competitive Comparison of Fractyl Health's Days Inventory

For the Biotechnology subindustry, Fractyl Health's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fractyl Health's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fractyl Health's Days Inventory distribution charts can be found below:

* The bar in red indicates where Fractyl Health's Days Inventory falls into.

Save Embed

;

Save Embed

;

Fractyl Health Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Fractyl Health's Days Inventory for the fiscal year that ended in Dec. 2024 is calculated as

	Days Inventory (A: Dec. 2024 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2023 )	+	Total Inventories (A: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2024 )	*	Days in Period
=	( (0.073	+	0.073)	/	2 )	/	0.05	*	365
=	0.073					/	0.05	*	365
=	532.90

Fractyl Health's Days Inventory for the quarter that ended in Dec. 2024 is calculated as:

	Days Inventory (Q: Dec. 2024 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Sep. 2024 )	+	Total Inventories (Q: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
=	( (0.073	+	0.073)	/	2 )	/	0	*	365 / 4
=	0.073					/	0	*	365 / 4
=	N/A

Fractyl Health (NAS:GUTS) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Fractyl Health's Inventory Turnover for the three months ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0	/	0.073
	=	0.00

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Fractyl Health's Inventory to Revenue for the three months ended in Dec. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0.073	/	0.003
	=	24.33

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Fractyl Health Days Inventory Related Terms

Thank you for viewing the detailed overview of Fractyl Health's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Fractyl Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fractyl Health Inc (NAS:GUTS) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

3 Van de Graaff Drive, Suite 200, Burlington, MA, USA, 01803

Website

https://www.fractyl.com

Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.